These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 12699395

  • 21. Design and synthesis of potent HIV-1 protease inhibitors incorporating hydroxyprolinamides as novel P2 ligands.
    Gao BL, Zhang CM, Yin YZ, Tang LQ, Liu ZP.
    Bioorg Med Chem Lett; 2011 Jun 15; 21(12):3730-3. PubMed ID: 21555220
    [Abstract] [Full Text] [Related]

  • 22. Enamino-oxindole HIV protease inhibitors.
    Eissenstat M, Guerassina T, Gulnik S, Afonina E, Silva AM, Ludtke D, Yokoe H, Yu B, Erickson J.
    Bioorg Med Chem Lett; 2012 Aug 01; 22(15):5078-83. PubMed ID: 22749283
    [Abstract] [Full Text] [Related]

  • 23. Synthesis of novel HIV protease inhibitors (PI) with activity against PI-resistant virus.
    Raghavan S, Lu Z, Beeson T, Chapman KT, Schleif WA, Olsen DB, Stahlhut M, Rutkowski CA, Gabryelski L, Emini E, Tata JR.
    Bioorg Med Chem Lett; 2007 Oct 01; 17(19):5432-6. PubMed ID: 17692518
    [Abstract] [Full Text] [Related]

  • 24. 4-hydroxy-5,6-dihydropyrones. 2. Potent non-peptide inhibitors of HIV protease.
    Tait BD, Hagen S, Domagala J, Ellsworth EL, Gajda C, Hamilton HW, Prasad JV, Ferguson D, Graham N, Hupe D, Nouhan C, Tummino PJ, Humblet C, Lunney EA, Pavlovsky A, Rubin J, Gracheck SJ, Baldwin ET, Bhat TN, Erickson JW, Gulnik SV, Liu B.
    J Med Chem; 1997 Nov 07; 40(23):3781-92. PubMed ID: 9371244
    [Abstract] [Full Text] [Related]

  • 25. Combination of non-natural D-amino acid derivatives and allophenylnorstatine-dimethylthioproline scaffold in HIV protease inhibitors have high efficacy in mutant HIV.
    Nakatani S, Hidaka K, Ami E, Nakahara K, Sato A, Nguyen JT, Hamada Y, Hori Y, Ohnishi N, Nagai A, Kimura T, Hayashi Y, Kiso Y.
    J Med Chem; 2008 May 22; 51(10):2992-3004. PubMed ID: 18426195
    [Abstract] [Full Text] [Related]

  • 26. Oximinoarylsulfonamides as potent HIV protease inhibitors.
    Yeung CM, Klein LL, Flentge CA, Randolph JT, Zhao C, Sun M, Dekhtyar T, Stoll VS, Kempf DJ.
    Bioorg Med Chem Lett; 2005 May 02; 15(9):2275-8. PubMed ID: 15837308
    [Abstract] [Full Text] [Related]

  • 27. Antiviral activity and cross-resistance profile of P-1946, a novel human immunodeficiency virus type 1 protease inhibitor.
    Sévigny G, Stranix B, Tian B, Dubois A, Sauvé G, Petropoulos C, Lie Y, Hellmann N, Conway B, Yelle J.
    Antiviral Res; 2006 Jun 02; 70(2):17-20. PubMed ID: 16473417
    [Abstract] [Full Text] [Related]

  • 28. Discovery of potent HIV-1 protease inhibitors incorporating sulfoximine functionality.
    Lu D, Vince R.
    Bioorg Med Chem Lett; 2007 Oct 15; 17(20):5614-9. PubMed ID: 17822899
    [Abstract] [Full Text] [Related]

  • 29. HIV-1 protease inhibitors with a transition-state mimic comprising a tertiary alcohol: improved antiviral activity in cells.
    Mahalingam AK, Axelsson L, Ekegren JK, Wannberg J, Kihlström J, Unge T, Wallberg H, Samuelsson B, Larhed M, Hallberg A.
    J Med Chem; 2010 Jan 28; 53(2):607-15. PubMed ID: 19961222
    [Abstract] [Full Text] [Related]

  • 30. Structure-based design of novel HIV-1 protease inhibitors to combat drug resistance.
    Ghosh AK, Sridhar PR, Leshchenko S, Hussain AK, Li J, Kovalevsky AY, Walters DE, Wedekind JE, Grum-Tokars V, Das D, Koh Y, Maeda K, Gatanaga H, Weber IT, Mitsuya H.
    J Med Chem; 2006 Aug 24; 49(17):5252-61. PubMed ID: 16913714
    [Abstract] [Full Text] [Related]

  • 31. Design and synthesis of new potent C2-symmetric HIV-1 protease inhibitors. Use of L-mannaric acid as a peptidomimetic scaffold.
    Alterman M, Björsne M, Mühlman A, Classon B, Kvarnström I, Danielson H, Markgren PO, Nillroth U, Unge T, Hallberg A, Samuelsson B.
    J Med Chem; 1998 Sep 24; 41(20):3782-92. PubMed ID: 9748353
    [Abstract] [Full Text] [Related]

  • 32. Solid-phase synthesis of HTLV-1 protease inhibitors containing hydroxyethylamine dipeptide isostere.
    Akaji K, Teruya K, Aimoto S.
    J Org Chem; 2003 Jun 13; 68(12):4755-63. PubMed ID: 12790579
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Structure-activity relationships of novel HIV-1 protease inhibitors containing the 3-amino-2-chlorobenzoyl-allophenylnorstatine structure.
    Mimoto T, Nojima S, Terashima K, Takaku H, Shintani M, Hayashi H.
    Bioorg Med Chem; 2008 Feb 01; 16(3):1299-308. PubMed ID: 17981045
    [Abstract] [Full Text] [Related]

  • 35. A Modified P1 Moiety Enhances In Vitro Antiviral Activity against Various Multidrug-Resistant HIV-1 Variants and In Vitro Central Nervous System Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413.
    Amano M, Salcedo-Gómez PM, Zhao R, Yedidi RS, Das D, Bulut H, Delino NS, Sheri VR, Ghosh AK, Mitsuya H.
    Antimicrob Agents Chemother; 2016 Dec 01; 60(12):7046-7059. PubMed ID: 27620483
    [Abstract] [Full Text] [Related]

  • 36. Synthesis and activity of N-acyl azacyclic urea HIV-1 protease inhibitors with high potency against multiple drug resistant viral strains.
    Zhao C, Sham HL, Sun M, Stoll VS, Stewart KD, Lin S, Mo H, Vasavanonda S, Saldivar A, Park C, McDonald EJ, Marsh KC, Klein LL, Kempf DJ, Norbeck DW.
    Bioorg Med Chem Lett; 2005 Dec 15; 15(24):5499-503. PubMed ID: 16203141
    [Abstract] [Full Text] [Related]

  • 37. Disubstituted Bis-THF Moieties as New P2 Ligands in Nonpeptidal HIV-1 Protease Inhibitors (II).
    Hohlfeld K, Wegner JK, Kesteleyn B, Linclau B, Unge J.
    J Med Chem; 2015 May 14; 58(9):4029-38. PubMed ID: 25897791
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles.
    Miller JF, Brieger M, Furfine ES, Hazen RJ, Kaldor I, Reynolds D, Sherrill RG, Spaltenstein A.
    Bioorg Med Chem Lett; 2005 Aug 01; 15(15):3496-500. PubMed ID: 15990305
    [Abstract] [Full Text] [Related]

  • 40. Synthesis of a new hydroxyethylene dipeptide isostere Phe psi [CH2CH (OH)]Phe as HIV-1 protease inhibitor.
    Chen HG, Sawyer TK, Wuts PG.
    Zhongguo Yao Li Xue Bao; 1994 Jan 01; 15(1):33-5. PubMed ID: 8010081
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.